Grant number: CRF14009 | Funding period: 2018 - 2020
Completed
H Fettke, EM Kwan, MM Docanto, P Bukczynska, N Ng, LJK Graham, K Mahon, C Hauser, W Tan, XH Wang, Z Zhao, T Zheng, K Zhou, P Du, J Yu, Y Huang, S Jia, M Kohli, LG Horvath, AA Azad
2020-08-01
Background: The androgen receptor (AR) remains a critical driver in metastatic castration-resistant prostate cancer (mCRPC). Profi..
M Kohli, W Tan, T Zheng, A Wang, C Montesinos, C Wong, P Du, S Jia, S Yadav, LG Horvath, KL Mahon, EM Kwan, H Fettke, J Yu, AA Azad
2020-04-01
Background: Metastatic prostate cancer is a clonally heterogeneous disease state characterized by progressive somatic perturbation..